PCN64 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PUBLIC HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
Abstract
Authors
N Muszbeck U Munir H Vioix A Schiola A Valderrama V Teich